Clinical trial of Medroxyprogestrone acetate and Tranexamic acid in women with menorrhagia
Not Applicable
- Conditions
- menorrhagia.Excessive and frequent menstruation with regular cycle
- Registration Number
- IRCT138802131641N3
- Lead Sponsor
- Research Asisstant of Tarbiat Modares University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 76
Inclusion Criteria
Age 20-45 years old, Regular menses, Heavy menstrual bleeding in several cycles, BMI 19-29
Exclusion criteria: Irregular menses or intra menstrual bleeding, Existence of uterine fibroids>3cm or other pathologic or iatrogenic causes for abnormal bleeding, Any systemic disease affecting menstrual bleeding, Using hormonal drugs (includes OCPs) or other drugs which influence on menstrual bleeding, Having intra uterine device, Pregnancy, Anemia (Hb<11), any therapeutic or preventive regimes for iron deficiency anemia
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Menstrual blood loss. Timepoint: one, two and three cycles after intervention. Method of measurement: by using pictorial blood loss assessment chart.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: before and after intervention. Method of measurement: by using Aberdeen menorrhagia Questionnaire.